Literature DB >> 16505461

What is the best evidence for determining harms of medical treatment?

Jan P Vandenbroucke1.   

Abstract

Mesh：

Year:  2006        PMID： 16505461      PMCID： PMC1389828          DOI： 10.1503/cmaj.051484

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  12 in total

Review 1.  Improving safety reporting from randomised trials.

Authors:  John P A Ioannidis; Joseph Lau
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

2.  Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90 000 Swedish women.

Authors:  Sarah Darby; Paul McGale; Richard Peto; Fredrik Granath; Per Hall; Anders Ekbom
Journal:  BMJ       Date:  2003-02-01

3.  When are observational studies as credible as randomised trials?

Authors:  Jan P Vandenbroucke
Journal:  Lancet       Date:  2004-05-22       Impact factor: 79.321

4.  The road to health care.

Authors:  Luis Gabriel Cuervo; Jeffrey K Aronson
Journal:  BMJ       Date:  2004-07-03

5.  Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies.

Authors:  Panagiotis N Papanikolaou; Georgia D Christidi; John P A Ioannidis
Journal:  CMAJ       Date:  2006-02-28       Impact factor: 8.262

6.  The need for randomization in the study of intended effects.

Authors:  O S Miettinen
Journal:  Stat Med       Date:  1983 Apr-Jun       Impact factor: 2.373

7.  Case-control studies in the evaluation of drug-induced illness.

Authors:  H Jick; M P Vessey
Journal:  Am J Epidemiol       Date:  1978-01       Impact factor: 4.897

8.  Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.

Authors:  James Shepherd; Gerard J Blauw; Michael B Murphy; Edward L E M Bollen; Brendan M Buckley; Stuart M Cobbe; Ian Ford; Allan Gaw; Michael Hyland; J Wouter Jukema; Adriaan M Kamper; Peter W Macfarlane; A Edo Meinders; John Norrie; Chris J Packard; Ivan J Perry; David J Stott; Brian J Sweeney; Cillian Twomey; Rudi G J Westendorp
Journal:  Lancet       Date:  2002-11-23       Impact factor: 79.321

9.  Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial.

Authors:  Paul S Aisen; Kimberly A Schafer; Michael Grundman; Eric Pfeiffer; Mary Sano; Kenneth L Davis; Martin R Farlow; Shelia Jin; Ronald G Thomas; Leon J Thal
Journal:  JAMA       Date:  2003-06-04       Impact factor: 56.272

10.  Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.

Authors:  Sally A Shumaker; Claudine Legault; Lewis Kuller; Stephen R Rapp; Leon Thal; Dorothy S Lane; Howard Fillit; Marcia L Stefanick; Susan L Hendrix; Cora E Lewis; Kamal Masaki; Laura H Coker
Journal:  JAMA       Date:  2004-06-23       Impact factor: 56.272
View more
  22 in total

1.  Registration of observational studies: is it time?

Authors:  Rebecca J Williams; Tony Tse; William R Harlan; Deborah A Zarin
Journal:  CMAJ       Date:  2010-07-19       Impact factor: 8.262

2.  Summarising the Evidence for Drug Safety: A Methodological Discussion of Different Meta-Analysis Approaches.

Authors:  Guillermo Prada-Ramallal; Bahi Takkouche; Adolfo Figueiras
Journal:  Drug Saf       Date:  2017-07       Impact factor: 5.606

3.  Safety of psychotropic medicines: contribution from observational evidence.

Authors:  H Verdoux
Journal:  Epidemiol Psychiatr Sci       Date:  2018-05-30       Impact factor: 6.892

Review 4.  A pathway to improved prospective observational post-authorization safety studies.

Authors:  Victor A Kiri
Journal:  Drug Saf       Date:  2012-09-01       Impact factor: 5.606

5.  Ranking evidence in substance use and addiction.

Authors:  Hudson Reddon; Thomas Kerr; M-J Milloy
Journal:  Int J Drug Policy       Date:  2020-07-06

6.  Short-term outcomes of pubertal suppression in a selected cohort of 12 to 15 year old young people with persistent gender dysphoria in the UK.

Authors:  Polly Carmichael; Gary Butler; Una Masic; Tim J Cole; Bianca L De Stavola; Sarah Davidson; Elin M Skageberg; Sophie Khadr; Russell M Viner
Journal:  PLoS One       Date:  2021-02-02       Impact factor: 3.240

Review 7.  Side effects of corticosteroids in patients with advanced cancer: a systematic review.

Authors:  Yutaka Hatano; Hiromichi Matsuoka; Lawrence Lam; David C Currow
Journal:  Support Care Cancer       Date:  2018-07-06       Impact factor: 3.603

8.  Caring for the older person with chronic obstructive pulmonary disease.

Authors:  Terri R Fried; Carlos A Vaz Fragoso; Michael W Rabow
Journal:  JAMA       Date:  2012-09-26       Impact factor: 56.272

9.  3-Month Results from Denmark within the Globally Prospective and Observational Study to Evaluate Insulin Detemir Treatment in Type 1 and Type 2 Diabetes: The PREDICTIVE Study.

Authors:  Kjeld Hermansen; Per Lund; Kurt Clemmensen; Leif Breum; Marianne Kleis Moller; Anne Mette Rosenfalck; Erik Christiansen
Journal:  Rev Diabet Stud       Date:  2007-08-10

Review 10.  Pharmacological treatment of neonatal seizures: a systematic review.

Authors:  Laurel A Slaughter; Anup D Patel; Jonathan L Slaughter
Journal:  J Child Neurol       Date:  2013-01-14       Impact factor: 1.987
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.